Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05779852` - Pain Management of Amputation Wounds With AutoHypnosis	N/A
Recruiting	`NCT05766579` - Comparison Trial Between Elastic-compressive Stockings at 21 Versus 32 mmHg	N/A
Not yet recruiting	`NCT04333693` - Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study

See also

Status

Clinical Trial

Phase

Recruiting

NCT05779852 - Pain Management of Amputation Wounds With AutoHypnosis

N/A

Recruiting

NCT05766579 - Comparison Trial Between Elastic-compressive Stockings at 21 Versus 32 mmHg

N/A

Not yet recruiting

NCT04333693 - Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01584193
Study type	Interventional
Source	University of Lausanne Hospitals
Contact
Status	Withdrawn
Phase	N/A
Start date	June 2013
Completion date	December 2014

Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection for Venous Access Port Implantation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms